Dasiglucagon(Zegalogue) acetate is a Glucagon Receptor Agonist. The physiologic effect of dasiglucagon is by means of Increased Glycogenolysis.
| Molecular Weight | 3441.7 |
| Formula | C154H226N38O52 |
| CAS Number | 1544300-84-6 (free base) |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
| Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
| Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
| Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
| Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
| Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
[1] No authors listed. Med Lett Drugs Ther. Dasiglucagon (Zegalogue) for severe hypoglycemia
[2] Bo Xu, et al. Eur J Clin Pharmacol. Dasiglucagon: an effective medicine for severe hypoglycemia
[3] Hannah A Blair. Drugs. Dasiglucagon: First Approval
[4] No authors listed. Expert Opin Pharmacother. Dasiglucagon
| Related Glucagon Receptor Products |
|---|
| Glucagon (19-29), human
Glucagon (19-29), human is a potent and efficient inhibitor of insulin secretion. |
| Exendin-3/4 (59-86)
Exendin-3/4 (59-86) is a Exendin-4 peptide derivative. |
| HAEGTFTSDVS
HAEGTFTSDVS is the first N-terminal 1-11 residues of GLP-1 peptide. |
| GLP-1(32-36)amide
GLP-1(32-36)amide, a pentapeptide, derived from the C terminus of the glucoregulatory hormone GLP-1. |
| HAEGTFTSD
HAEGTFTSD is a 9-residue peptide of human GLP-1 peptide or GLP-1(7-36), amide. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
